Free Trial

biote (BTMD) Stock Price, News & Analysis

-0.07 (-1.24%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
122,667 shs
Average Volume
108,281 shs
Market Capitalization
$345.56 million
P/E Ratio
Dividend Yield
Price Target

biote MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
45.6% Upside
$8.11 Price Target
Short Interest
3.25% of Float Sold Short
Dividend Strength
News Sentiment
0.95mentions of biote in the last 14 days
Based on 4 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.30 out of 5 stars

Medical Sector

515th out of 920 stocks

Medicinals & Botanicals Industry

5th out of 11 stocks

BTMD stock logo

About biote Stock (NASDAQ:BTMD)

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

BTMD Stock Price History

BTMD Stock News Headlines

Short Interest in biote Corp. (NASDAQ:BTMD) Increases By 6.8%
Biote Announces Definitive Settlement with Founder
Preview: Biote's Earnings
Birmingham manufacturer to be acquired for $8.5M
Biote price target lowered by $1 at Truist, here's why
See More Headlines
Receive BTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Medicinals & botanicals
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
$3.32 million
Pretax Margin


Sales & Book Value

Annual Sales
$185.36 million
Cash Flow
$0.48 per share
Book Value
($0.58) per share


Free Float
Market Cap
$345.56 million
Not Optionable
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

BTMD Stock Analysis - Frequently Asked Questions

Should I buy or sell biote stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for biote in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BTMD shares.
View BTMD analyst ratings
or view top-rated stocks.

What is biote's stock price target for 2024?

5 Wall Street analysts have issued 12 month price targets for biote's stock. Their BTMD share price targets range from $6.55 to $9.00. On average, they predict the company's stock price to reach $8.11 in the next year. This suggests a possible upside of 45.6% from the stock's current price.
View analysts price targets for BTMD
or view top-rated stocks among Wall Street analysts.

How have BTMD shares performed in 2024?

biote's stock was trading at $4.94 on January 1st, 2024. Since then, BTMD stock has increased by 12.8% and is now trading at $5.57.
View the best growth stocks for 2024 here

When is biote's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024.
View our BTMD earnings forecast

How were biote's earnings last quarter?

biote Corp. (NASDAQ:BTMD) posted its earnings results on Tuesday, March, 12th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.06. The company earned $45.70 million during the quarter, compared to analyst estimates of $45.50 million. biote had a negative trailing twelve-month return on equity of 36.67% and a net margin of 4.30%.

What guidance has biote issued on next quarter's earnings?

biote updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $200.0 million-$204.0 million, compared to the consensus revenue estimate of $202.3 million.

Who are biote's major shareholders?

biote's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.88%), Wasatch Advisors LP (0.90%) and Acadian Asset Management LLC (0.16%). Insiders that own company stock include Mary Elizabeth Conlon, Roystone Capital Management Lp and Samar Jagat Kamdar.
View institutional ownership trends

How do I buy shares of biote?

Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BTMD) was last updated on 5/21/2024 by Staff

From Our Partners